Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Eric J. Silberfein"'
Autor:
Francesco Izzo, Meredith C. Mason, Eric J. Silberfein, Nader N. Massarweh, Cary Hsu, Hop S. Tran Cao, Raffaele Palaia, Mauro Piccirillo, Andrea Belli, Renato Patrone, Roberta Fusco, Vincenza Granata, Steven A. Curley
Publikováno v:
Biology, Vol 11, Iss 11, p 1597 (2022)
Background: We initiated a prospective screening trial in patients with hepatitis to diagnose HCC in the early stage and to evaluate the impact on long-term survival. Methods: From 1993–2006, 10,372 patients with chronic hepatitis B (14%), hepatiti
Externí odkaz:
https://doaj.org/article/dcbf3d3474974f419952955632403d3d
Autor:
Taylor M. Gilliland, Nicole Villafane-Ferriol, Kevin P. Shah, Rohan M. Shah, Hop S. Tran Cao, Nader N. Massarweh, Eric J. Silberfein, Eugene A. Choi, Cary Hsu, Amy L. McElhany, Omar Barakat, William Fisher, George Van Buren
Publikováno v:
Nutrients, Vol 9, Iss 3, p 243 (2017)
Pancreatic cancer is an aggressive malignancy with a poor prognosis. The disease and its treatment can cause significant nutritional impairments that often adversely impact patient quality of life (QOL). The pancreas has both exocrine and endocrine f
Externí odkaz:
https://doaj.org/article/c5c35bf7746645038b2e954250f60100
Autor:
T. Alston Mickel, Onur C. Kutlu, Eric J. Silberfein, Cary Hsu, Christy Y. Chai, William E. Fisher, George Van Buren, E. Ramsay Camp
Publikováno v:
The American Journal of Surgery. 224:635-640
Return to Intended Oncologic Treatment (RIOT) has been proposed as a quality metric in the care of cancer patients. We sought to define factors associated with inability to RIOT in Pancreatic Ductal Adenocarcinoma (PDAC) patients.The NCDB was queried
Autor:
Emily L. Ryon, Sommer Luu, Joshua P. Kronenfeld, Annie Wang, Maria C. Russell, Neha Goel, Adam C. Yopp, Ann Y. Lee, David S. Goldberg, Eric J. Silberfein, Nipun B. Merchant, Rachel M. Lee, Cary Hsu
Publikováno v:
HPB (Oxford)
BACKGROUND: Access to health insurance and curative interventions [surgery/liver directed therapy (LDT)] affects survival for early-stage hepatocellular carcinoma (HCC). The aim of this multi-institutional study of high-volume safety-net hospitals (S
Autor:
Shishir K. Maithel, Eric J. Silberfein, Cary Hsu, Maria C. Russell, Emily L. Ryon, Annie Wang, Rachel M. Lee, Sommer Luu, Michael K. Turgeon, Neha Goel, Adam C. Yopp, Adriana C. Gamboa, Ann Y. Lee
Publikováno v:
HPB (Oxford)
BACKGROUND: Widespread HCV treatment for hepatocellular carcinoma (HCC) patients remains limited. Our aim was to evaluate the association of HCV treatment with survival and assess barriers to treatment. METHODS: Patients in the U.S. Safety Net Collab
Publikováno v:
Journal of Surgical Research. 256:374-380
Background Safety net hospitals have historically cared for a disproportionate number of patients of low socioeconomic status, racial and ethnic minorities, and patients with cancer. These innate challenges make safety net hospitals important in unde
Autor:
Bradford G. Scott, Todd K. Rosengart, Nader N. Massarweh, Scott A. LeMaire, Barbara W. Trautner, William C. Frankel, Eric J. Silberfein, Qianzi Zhang
Publikováno v:
Journal of Surgical Education. 77:1082-1087
Objective Surgeon-scientists are becoming increasingly scarce, and therefore, engaging residents in research during their training is important. We evaluated whether a multifaceted research engagement program was associated with increased academic pr
Autor:
Joshua P. Kronenfeld, Sommer Luu, Michael K. Turgeon, Adriana C. Gamboa, Cary Hsu, Annie Wang, Adam C. Yopp, Emily L. Ryon, Ann Y. Lee, Maria C. Russell, Eric J. Silberfein, Neha Goel, Shishir K. Maithel, Rachel M. Lee
Publikováno v:
Am Surg
Background Hepatitis C virus (HCV) has historically been the most common cause of cirrhosis and hepatocellular carcinoma (HCC) in the United States. With improved HCV treatment, cirrhosis secondary to other etiologies is increasing. Given this changi
Autor:
Katherine A. Baugh, Omar Barakat, Cary Hsu, Amy L. McElhany, Nicole Villafane-Ferriol, Andrew Fang, Nader N. Massarweh, Jose E. Mendez Reyes, Eric J. Silberfein, Carl Schmidt, Nicholas J. Zyromski, Erisha K. Tashakori, Hop S. Tran Cao, George Van Buren, Mary Dillhoff, William E. Fisher, Joshua A. Villarreal
Publikováno v:
Journal of Surgical Research. 236:332-339
Early drain removal when postoperative day (POD) one drain fluid amylase (DFA) was ≤5000 U/L reduced complications in a previous randomized controlled trial. We hypothesized that most surgeons continue to remove drains late and this is associated w